Key result
CMR detects epicardial and microvascular thrombosis in a COVID-19 patient with acute myocardial injury.
Why the study?
Cardiovascular magnetic resonance imaging can identify underlying pathology in patients with acute myocardial injury secondary to COVID-19.
CMR is useful in identifying complex underlying pathologies, such as concurrent epicardial and microvascular thrombosis, in COVID-19 patients with acute myocardial injury.
CMR may identify mixed thrombosis in COVID-19 myocardial injury; single case leaves open diagnostic utility and generalizability.
In patients with acute myocardial injury secondary to coronavirus disease-2019 (COVID-19), cardiovascular magnetic resonance imaging can identify the underlying pathology. We highlight a case of acute myocardial injury secondary to COVID-19, which demonstrated both epicardial vessel thrombosis and the recently described phenomenon of microvascular thrombosis. (Level of Difficulty: Advanced.)
No takes yet. Share an insight, caveat, or question.
Gorecka et al. (2021) studied this question. Cardiovascular magnetic resonance imaging identified both epicardial vessel thrombosis and microvascular thrombosis in a COVID-19 patient with acute myocardial injury.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: